BACKGROUND/OBJECTIVES: Alkylresorcinols (ARs) have been suggested as biomarkers of whole-grain wheat and rye intake. Plasma AR concentrations have a short half-life; hence, long-term biomarkers are needed. This study evaluated the responsiveness of ARs in adipose tissue biopsies as biomarkers after a whole-grain intake intervention. SUBJECTS/METHODS: Samples and data of 27 participants from a 12-week randomized parallel-group dietary intervention were available. The participants were replacing their habitual diet with a whole-grain-enriched diet (WGDG) or a refined grain diet (RDG) during the intervention. Blood samples and adipose tissue biopsies were collected at baseline and after 12 weeks, and AR concentrations in the plasma and adipose tissues from the participants were compared against estimated whole-grain intake. RESULTS: AR concentrations in the adipose tissue and plasma did not change after 12 weeks in the WGDG group, as no significant increase in whole-grain intake was observed, but was significantly lower than baseline in the RDG group (P o 0.05), owing to decreased whole-grain intake in this group. Plasma and adipose tissue AR concentrations were significantly higher in the WGDG group than in the RDG group (P o0.05), and were highly correlated with average whole-grain intake estimated by food records (Spearman's r = 0.60-0.72 (P o0.05, n = 16) for total and individual AR homolog concentrations in the plasma; r = 0.60--0.84, (P o0.05, n = 16) for total and individual AR homolog concentrations in the adipose tissue). CONCLUSIONS: In this small pilot study, AR concentrations in adipose tissue responded to reduced intake of whole grain over 12 weeks. Although not significantly different from plasma AR, adipose tissue AR concentrations were highly correlated with wholegrain intake after a 12-week intervention. These results show that adipose tissue AR concentrations have promise as biomarkers of whole-grain wheat and rye intake. Larger studies are needed to evaluate whether they are better long-term biomarkers than AR in the plasma.
INTRODUCTION
Epidemiological studies consistently show a reduced risk of colorectal cancer, type 2 diabetes and cardiovascular disease in different populations when comparing high versus low wholegrain intake. [1] [2] [3] [4] [5] Whole-grain foods are rich in dietary fiber, vitamins, minerals, lignans and other phytochemicals, which may contribute to the lowered risk. 6, 7 In epidemiological studies, food frequency questionnaires are typically used to assess whole-grain intake, [8] [9] [10] but this method is prone to systematic and random measurement errors that may affect the accuracy of intake estimation. 11, 12 Factors that could influence accuracy include number of questions, quality of food databases, and ability and motivation of participants to distinguish their intake. 13, 14 Whole-grain intake can be particularly difficult to assess accurately, owing to lack of a uniform definition of whole-grain foods and to large variations in product content. 15, 16 To overcome these limitations, new biomarkers of whole-grain intake are currently being developed as a complementary intake ranking tool. 17 Alkylresorcinols (ARs) are phenolic lipids mainly present in the bran of wheat and rye, among commonly consumed foods, and have been evaluated and used as a biomarker of these cereals. 4, [18] [19] [20] ARs comprise 1,3-dihydroxy-5-alkylbenzene homologs with mainly odd number carbon atom side chains in the range 17-25 (C17:0, C19:0, C21:0, C23:0 and C25:0). 21 The AR profile in different cereals is unique and the source of whole grain can be traced by calculating the C17:0 to C21:0 ratio, which is about 1.0 for rye, 0.1 for common wheat and 0.01 for durum wheat. 22, 23 ARs are stable during food processing, 22 absorbed in the gastrointestinal tract and can be analyzed in the plasma 24, 25 and adipose tissue. 26, 27 AR concentrations in a single plasma sample reflect long-term intake with acceptable precision, despite short apparent half-life (~5 h), in populations where wheat and rye are the main sources of whole-grain intake and where intake is frequent and stable. [28] [29] [30] However, in populations with low or irregular intake, more long-term biomarkers are needed.
AR concentrations in adipose tissue may better reflect longterm exposure, as the turnover rate is slower than in the plasma. 31 A pilot study in women from the Swedish mammography cohort showed that ARs are present in human adipose tissue, and that the concentrations are correlated with whole-grain food intake, as estimated by a food frequency questionnaire. 27 However, before using ARs in the adipose tissue as long-term biomarkers of wholegrain intake, the responsiveness of AR concentrations in adipose tissue to changes in diet needs to be evaluated and compared with that in the plasma under conditions where intake of whole grain varies. The aim of the present study was therefore to evaluate the response of adipose tissue AR concentrations in available adipose tissue samples from men and women after a 12-week dietary whole-grain intervention study.
MATERIALS AND METHODS

Study population, study design and samples
We obtained access to adipose tissue biopsy samples and plasma samples from subjects (n = 27) participating in a 12-week controlled, parallel dietary intervention study (SYSDIMET, ClinicalTrials.gov Identifier: NCT00573781) conducted in Finland. 32 Participants were men and women aged 47-65 years with impaired glucose metabolism as indicated by a 2-h oral glucose tolerance test. Plasma glucose concentration at 2 h was 7.8-11.0 mmol/l and fasting plasma glucose concentration was 5.2-7.8 mmol/l. At least two of the following criteria were met by the subjects: body mass index, 26-39 kg/m 2 ; waist circumference, ⩾ 88 cm in women and ⩾ 102 cm in men; serum triglycerides, ⩾ 1.7 mmol/l; high-density lipoprotein-cholesterol, o1.3 mmol/l in women and o1.0 mmol/l in men; and blood pressure, ⩾ 130/ ⩾ 85 mm Hg or use of medication for hypertension.
In the SYSDIMET study, the participants (n = 131) were randomly allocated to one of three dietary intervention groups: a healthy diet (high intake of whole grain, fatty fish and blueberries) group, a whole-grainenriched diet group (WGDG) and a control group with refined wheat products. In the present study, data on participants from the healthy diet group and the WGDG group were merged into one WGDG (n = 17), as both these groups were advised to have equal whole-grain intake. Samples and data from 10 participants in the control group with refined wheat products (refined grain diet (RDG)) were also available. Participants in the WGDG group were instructed to replace their habitual cereal products with products that contained more than 50% whole grain. Moreover, participants were asked to consume at least 35 g (weight before cooking) whole-grain pasta per day, while 1 daily portion of other cereal products habitually consumed by subjects was permitted. In addition, whole-grain oat snack bars were provided once a day on a voluntary basis. In total, advised whole-grain intake for the WGDG group corresponded Table 1 . Whole-grain intake and AR concentrations in the plasma and AT of the WGDG (n = 17) and RDG (n = 10) during the 12-week intervention The Wilcoxon signed-rank test was used to compare each parameter within groups between baseline and treatment. Whole-grain intake (g/day) was estimated based on amount of reported products and data on their whole-grain content provided by the manufacturer.
d Whole-grain intake data were available for n = 16 participants in the WGDG group.
e Mann-Whitney's U-test was used to compare each parameter between the WGDG and the RDG groups.
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to 20%-25% of participants' total daily energy intake. In the control group (RDG), participants were asked to consume refined cereal products instead of their habitual breads. 33 The study was approved by the ethics committee of the hospital district of Northern Savo (permission number 56/2007) and informed consent was obtained from all subjects.
Data collection and biochemical analyses
Whole-grain product intake was estimated using 4-day food records with consecutive predefined days including 1 weekend day collected from subjects in the week before (week 0) and in weeks 3, 7 and 11 of the intervention. 33 Whole-grain intake (g/day) was estimated based on reported products and data on their whole-grain content provided by the manufacturer. Whole-grain intake data were not available for the participants originating from the healthy diet group (n = 10) and data for one individual from the WGDG group in the SYSDIMET study were lacking. Plasma and adipose tissue samples were collected from all subjects before (week 0) and at the end of the study (week 12). All blood samples and adipose tissue samples were collected after 12-h overnight fasting. Blood samples were drawn through a catheter in an antecubital vein. Adipose tissue biopsy samples were collected from the superficial abdominal subcutaneous adipose tissue lateral to the umbilicus by open biopsy under local anesthesia (10 mg Lidocaine/ml; Orion Pharma, Espoo, Finland) and washed twice with Gibco phosphate-buffered saline (Invitrogen, Carlsbad, CA, USA). All samples were stored at − 80°C until analysis. AR concentrations in the plasma (200 μl) and the adipose tissue (10-25 mg) were analyzed by gas chromatography-mass spectrometry. 27, 34 Data analysis Whole-grain intake values from weeks 3, 7 and 11 were averaged and represented whole-grain intake during intervention. As plasma and adipose AR concentrations were right skewed in the study sample and the sample size was small, non-parametric statistical methods were used. The median and the 25th and 75th percentiles of AR concentrations in the plasma and adipose tissues were calculated for both groups. Differences in whole-grain intake and in AR concentration in the plasma and adipose tissue before and after intervention in both groups were tested using Wilcoxon's signed-rank test. Differences in whole-grain intake and in AR concentration in the plasma and adipose tissue between the WGDG and RDG groups were tested using the Mann-Whitney's U-test. Relationships between whole-grain intake, plasma AR concentrations and adipose tissue AR concentrations of all subjects were assessed by Spearman's rank correlation coefficients. Two-sided tests were used and Po 0.05 was defined as statistically significant. All statistical analyses were conducted using SAS 9.3 for Windows (SAS Institute Inc., Cary, NC, USA).
RESULTS
No difference in whole-grain intake was observed between the WGDG and the RDG groups at baseline (Table 1) . However, as expected, whole-grain intake decreased significantly in the RDG group, while it remained unchanged in the WGDG group during the 12-week intervention. The results for ARs in the plasma and adipose tissue reflected the changes in intake of whole grain. The concentration of AR homologs in the plasma and adipose tissue did not differ between the WGDG and the RDG groups at baseline (P40.05) ( Table 1 ). However, after the intervention, individual AR homolog concentrations and their sum in RDG plasma and adipose tissue samples were significantly lower than at baseline. No such differences in plasma or adipose tissue AR concentrations during the intervention were observed for the WGDG samples, as could be expected from the lack of changes in intake (Table 1) . After 12 weeks, AR concentrations in the plasma and adipose tissue were significantly higher for the WGDG group than for the RDG group (P o0.05) ( Table 1) .
No significant correlations between whole-grain intake and plasma AR or adipose tissue AR concentrations were observed at baseline. Moreover, plasma AR concentrations were not significantly correlated with adipose tissue AR concentrations at baseline. At the end of the 12-week intervention, intake of whole grain was in general significantly correlated with individual and total AR homolog concentrations in the plasma (r = 0.60-0.72, Po 0.05) and in the adipose tissue (r = 0.60-0.84, Po 0.05) (Figures 1 and 2) . Plasma AR concentrations were correlated with adipose tissue after the 12-week intervention (Figures 1 and 2) . DISCUSSION This is the first study to evaluate the responsiveness of adipose tissue AR concentrations in a whole-grain intervention study. The degree of responsiveness to 12-week intake will strongly affect the usefulness of a long-term biomarker.
At baseline, the plasma AR concentrations in both the WGDG and RDG groups were similar and concentrations were in the range reported previously for the Nordic countries. 19, [35] [36] [37] The plasma AR concentrations did not change in the WGDG group during the 12-week intervention, but AR concentrations were significantly reduced (by two-thirds) in the RDG group, showing that plasma AR concentrations responded in parallel with reduced intake of whole-grain products ( Table 1 ). The high whole-grain intake observed at baseline is supported by observations made in the National Findiet 2012 survey, showing that elderly people consume more whole grain than younger people, and that consumption is higher in the northern/eastern part of Finland than in the south. 38 This high baseline intake also explains why no increase occurred during the intervention phase.
The total concentration of ARs in the adipose tissue has only been reported once previously (0.54 μg/g in free-living Swedish women 27 ). The average adipose tissue AR concentration at baseline in the present study was of a similar magnitude (0.68 μg/g). Adipose tissue AR concentrations were not changed in the WGDG group and decreased in the RDG group after the 12-week intervention. This was consistent with the changes in whole-grain intake and plasma AR concentrations, and clearly shows that a 12-week period is sufficient to affect AR turnover in adipose tissues.
There was no significant association between whole-grain intake and plasma or adipose tissue AR at baseline. This may be Figure 1 . Spearman's rank correlation coefficients for whole-grain intake (WGI) and alkylresorcinol homolog C17:0-C25:0 concentrations in the plasma and adipose tissue (AT) at week 12 (treatment).
a Whole-grain intake data were not available for the participants from the healthy diet group (n = 10) and data for one individual in the WGDG group in the SYSDIEMT study were lacking. NS, not significant; *P o0.05, **P o0.01 and ***Po0.001.
due to a limited whole-grain intake range and/or due to large daily fluctuations in intake of AR-containing foods when participants consumed their habitual diet. Difficulties in capturing this with high precision when using 4-day food records probably resulted in a weak correlation to plasma AR concentration in our relatively small group of participants. 39 The lack of correlation with adipose tissue AR concentration may be owing to the fact that 4-day food records reflect short-term intake in study with a limited number of individuals, whereas the AR concentration in the adipose tissue may reflect long-term intake and is not necessarily reflected by food intake reported during 4 days at baseline. Moreover, intake of non-AR containing whole-grain food (such as oat and brown rice) would contribute to the whole-grain intake but not to AR concentrations in the plasma and adipose tissue. After 12 weeks, plasma total AR concentrations and adipose tissue total AR concentrations were both strongly correlated with wholegrain intake. In fact, the correlation coefficients for adipose tissue AR appeared stronger than has been observed previously for intake of whole grain or whole-grain products and plasma AR concentrations, 35, 40, 41 urine AR metabolites 35, 42 and adipose tissue AR concentrations. 27 However, no significant difference between correlation coefficients for whole-grain intake and plasma AR and adipose tissue AR was found in the presentation study (data not shown), likely owing to the small sample size. The strong correlation coefficients observed in the present study are probably the result of high, frequent intake of whole grain under dietary intervention conditions and suggest longer turnover rate of AR in the adipose tissue. Repeated measurements are needed to prove whether AR concentrations in the adipose tissue have a longer turnover rate; however, the fact that AR in adipose tissues responded to differences in intake over a 12-week period suggests that the turnover rate of AR in the adipose tissue is faster than that of some other lipophilic compounds in the adipose tissue. [43] [44] [45] This may be due to loose incorporation of AR with the membranes of adipocytes, as has been shown previously for tocopherols, tocotrienols and AR in erythrocyte membranes. [46] [47] [48] Other compounds such as triglycerides in adipocytes may have a longer turnover rate due to being incorporated into cytoplasmic lipid droplets. 49 The responsiveness was somewhat different for the different homologs, possibly owing to differences in incorporation and/or liberation kinetics. However, owing to the small sample size this result should be interpreted with caution.
In summary, we found that AR in the adipose tissue responded to changes in whole-grain intake during a 12-week advised intervention where wheat and rye were the main sources of whole grains. Moreover, whole-grain intake was highly correlated with adipose tissue AR concentrations. These results strongly support the use of ARs in adipose tissues as biomarkers for whole-grain intake in studies where such samples are available and where wheat and rye are the main sources of whole-grain intake. However, before applying adipose tissue AR as biomarkers in epidemiological studies, the turnover rate, non-dietary determinants and the variation in AR adipose tissue in larger free-living populations need to be investigated.
